Real-World Assessment of Patient Care and Practice Efficiency With the Introduction of Subcutaneous Rituximab
ONCOLOGY · 2021
DOI: 10.46883/2021.25920935 ↗Kurz gefasst
Fachartikel in der Zeitschrift ONCOLOGY, 2021. Verfasst von Esther Drill und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
- Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
- Evidence for Access, Genentech, Inc, South San Francisco, CA, USA.
- US Medical Affairs, Genentech, Inc, South San Francisco, CA, USA.
Zitieren
APA
Drill, E., Qiu, A., Shapouri, S., To, T. M., Ravelo, A., Schade, J., Dawson, K., & Matasar, M. (2021). Real-World Assessment of Patient Care and Practice Efficiency With the Introduction of Subcutaneous Rituximab. ONCOLOGY. https://doi.org/10.46883/2021.25920935
Vancouver
Drill E, Qiu A, Shapouri S, To TM, Ravelo A, Schade J, et al. Real-World Assessment of Patient Care and Practice Efficiency With the Introduction of Subcutaneous Rituximab. ONCOLOGY. 2021. doi:10.46883/2021.25920935
BibTeX
@article{Drill2021,
author = {Drill, Esther and Qiu, Annie and Shapouri, Sheila and To, Tu My and Ravelo, Arliene and Schade, Jake and Dawson, Keith and Matasar, Matthew},
title = {Real-World Assessment of Patient Care and Practice Efficiency With the Introduction of Subcutaneous Rituximab},
journal = {ONCOLOGY},
year = {2021},
doi = {10.46883/2021.25920935}
}
EUVIMED